Postmarket Safety

Diabetes Meds Linked to Heart Failure

Following a safety review, the FDA has decided to add warnings to the labels of Type 2 diabetes drugs containing saxagliptin and alogliptin due to the increased risk of heart failure in patients with kidney or heart disease. Read More